These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28640219)

  • 1. Topical Application of Trisodium Ascorbyl 6-Palmitate 2-Phosphate Actively Supplies Ascorbate to Skin Cells in an Ascorbate Transporter-Independent Manner.
    Shibuya S; Sakaguchi I; Ito S; Kato E; Watanabe K; Izuo N; Shimizu T
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28640219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate.
    Smart RC; Huang MT; Han ZT; Kaplan MC; Focella A; Conney AH
    Cancer Res; 1987 Dec; 47(24 Pt 1):6633-8. PubMed ID: 3677097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen synthesis in human skin fibroblasts is stimulated by a stable form of ascorbate, 2-O-alpha-D-glucopyranosyl-L-ascorbic acid.
    Yamamoto I; Muto N; Murakami K; Akiyama J
    J Nutr; 1992 Apr; 122(4):871-7. PubMed ID: 1552361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ascorbic acid and ascorbic acid 2-O-alpha-glucoside on the cytotoxicity and bioavailability to low density cultures of fibroblasts.
    Murakami K; Muto N; Fukazawa K; Yamamoto I
    Biochem Pharmacol; 1992 Dec; 44(11):2191-7. PubMed ID: 1472084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of free radical-induced cytotoxicity by 2-O-α-D-glucopyranosyl-L-ascorbic acid in human dermal fibroblasts.
    Hanada Y; Iomori A; Ishii R; Gohda E; Tai A
    Biosci Biotechnol Biochem; 2014; 78(2):301-6. PubMed ID: 25036685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antioxidant activity and in vivo efficacy of topical formulations containing vitamin C and its derivatives studied by non-invasive methods.
    Campos PM; Gonçalves GM; Gaspar LR
    Skin Res Technol; 2008 Aug; 14(3):376-80. PubMed ID: 19159387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation and metabolism of a novel ascorbic acid derivative, disodium isostearyl 2-O-L-ascorbyl phosphate, in human living skin equivalent models.
    Shibayama H; Hisama M; Matsuda S; Ohtsuki M
    Skin Pharmacol Physiol; 2008; 21(4):235-43. PubMed ID: 18552525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-oxidative and anti-aging activities of 2-O-α-glucopyranosyl-L-ascorbic acid on human dermal fibroblasts.
    Taniguchi M; Arai N; Kohno K; Ushio S; Fukuda S
    Eur J Pharmacol; 2012 Jan; 674(2-3):126-31. PubMed ID: 22119379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ascorbyl palmitate in topical microemulsions.
    Spiclin P; Gasperlin M; Kmetec V
    Int J Pharm; 2001 Jul; 222(2):271-9. PubMed ID: 11427357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of collagen synthesis by select calcium and sodium channel blockers can be mitigated by ascorbic acid and ascorbyl palmitate.
    Ivanov V; Ivanova S; Kalinovsky T; Niedzwiecki A; Rath M
    Am J Cardiovasc Dis; 2016; 6(2):26-35. PubMed ID: 27335688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of ascorbyl palmitate to produce the ascorbyl radical in vitro: an electron spin resonance investigation.
    Pokorski M; Gonet B
    Physiol Res; 2004; 53(3):311-6. PubMed ID: 15209539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effect of 2-O-alpha-D-glucopyranosyl-L-ascorbic acid, a stable ascorbic acid derivative, on collagen synthesis.
    Kumano Y; Sakamoto T; Egawa M; Tanaka M; Yamamoto I
    Biol Pharm Bull; 1998 Jul; 21(7):662-6. PubMed ID: 9703245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium ascorbyl phosphate in topical microemulsions.
    Spiclin P; Homar M; Zupancic-Valant A; Gasperlin M
    Int J Pharm; 2003 Apr; 256(1-2):65-73. PubMed ID: 12695012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
    Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
    Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
    Fischer AP; Miles SL
    Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perifollicular pigmentation is the first target for topical vitamin C derivative ascorbyl 2-phosphate 6-palmitate (APPS): randomized, single-blinded, placebo-controlled study.
    Inui S; Itami S
    J Dermatol; 2007 Mar; 34(3):221-3. PubMed ID: 17291309
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts.
    Maione-Silva L; de Castro EG; Nascimento TL; Cintra ER; Moreira LC; Cintra BAS; Valadares MC; Lima EM
    Sci Rep; 2019 Jan; 9(1):522. PubMed ID: 30679479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts.
    Kishimoto Y; Saito N; Kurita K; Shimokado K; Maruyama N; Ishigami A
    Biochem Biophys Res Commun; 2013 Jan; 430(2):579-84. PubMed ID: 23228664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy.
    Raschke T; Koop U; Düsing HJ; Filbry A; Sauermann K; Jaspers S; Wenck H; Wittern KP
    Skin Pharmacol Physiol; 2004; 17(4):200-6. PubMed ID: 15258452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.